Carlsmed, Inc. Total Liabilities
Carlsmed, Inc. total liabilities. Based on the latest financial reports, Carlsmed, Inc. (CARL) has total liabilities worth $33.96 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Carlsmed, Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Carlsmed, Inc. (2023–2025)
Total liabilities of Carlsmed, Inc. from 2023 to 2025. This chart illustrates how Carlsmed, Inc.'s total liabilities have evolved over time, based on quarterly financial data.
Carlsmed, Inc. Competitors by Total Liabilities
The table below lists competitors of Carlsmed, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Heidelberger Druckmaschinen Aktiengesellschaft
F:HDD
|
Germany | €1.59 Billion |
|
Songz Automobile Air Conditioning Co Ltd
SHE:002454
|
China | CN¥3.64 Billion |
|
Israel Land Development Company Co Ltd
TA:ILDC
|
Israel | ILA7.45 Billion |
|
Tianjin Saixiang Technology Co Ltd
SHE:002337
|
China | CN¥592.48 Million |
|
Gigasolar Materials
TWO:3691
|
Taiwan | NT$5.37 Billion |
|
Shenzhen Huakong Seg Co Ltd
SHE:000068
|
China | CN¥2.72 Billion |
|
XMax Inc.
NASDAQ:XMAX
|
USA | $6.79 Million |
|
Epigral Ltd.
NSE:EPIGRAL
|
India | Rs-22.21 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down Carlsmed, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Carlsmed, Inc. assets under control.
Liquidity & Leverage Metrics
Carlsmed, Inc. Total Liabilities Ratios Explained
Carlsmed, Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Carlsmed, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Carlsmed, Inc. (2023–2025)
The table below shows the annual total liabilities of Carlsmed, Inc. from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $31.25 Million | -74.48% |
| 2024-12-31 | $122.45 Million | +103.57% |
| 2023-12-31 | $60.15 Million | -- |
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more